| Advances in vaccine adjuvants M Singh, D O'Hagan Nature biotechnology 17 (11), 1075-1081, 1999 | 694 | 1999 |
| Nonviral delivery of self-amplifying RNA vaccines AJ Geall, A Verma, GR Otten, CA Shaw, A Hekele, K Banerjee, Y Cu, ... Proceedings of the National Academy of Sciences 109 (36), 14604-14609, 2012 | 690 | 2012 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 662 | 2021 |
| Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome FA Sharp, D Ruane, B Claass, E Creagh, J Harris, P Malyala, M Singh, ... Proceedings of the National Academy of Sciences 106 (3), 870-875, 2009 | 650 | 2009 |
| Cationic microparticles: a potent delivery system for DNA vaccines M Singh, M Briones, G Ott, D O'Hagan Proceedings of the National Academy of Sciences 97 (2), 811-816, 2000 | 621 | 2000 |
| COVID-19 vaccine acceptance among health care workers in the United States R Shekhar, AB Sheikh, S Upadhyay, M Singh, S Kottewar, H Mir, E Barrett, ... Vaccines 9 (2), 119, 2021 | 617 | 2021 |
| Recent developments in adjuvants for vaccines against infectious diseases DT O'Hagan, ML MacKichan, M Singh Biomolecular engineering 18 (3), 69-85, 2001 | 468 | 2001 |
| Recent advances in vaccine adjuvants M Singh, DT O'Hagan Pharmaceutical research 19, 715-728, 2002 | 349 | 2002 |
| A cationic nanoemulsion for the delivery of next-generation RNA vaccines LA Brito, M Chan, CA Shaw, A Hekele, T Carsillo, M Schaefer, J Archer, ... Molecular Therapy 22 (12), 2118-2129, 2014 | 331 | 2014 |
| Nanoparticles and microparticles as vaccine-delivery systems M Singh, A Chakrapani, D O’Hagan Expert review of vaccines 6 (5), 797-808, 2007 | 324 | 2007 |
| Poly (lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines D T O'Hagan, M Singh, RK Gupta Advanced Drug Delivery Reviews 32 (3), 225-246, 1998 | 323 | 1998 |
| Recent advances in veterinary vaccine adjuvants M Singh, D T O'Hagan International journal for parasitology 33 (5-6), 469-478, 2003 | 292 | 2003 |
| Microparticles as vaccine adjuvants and delivery systems DT O’Hagan, M Singh Expert review of vaccines 2 (2), 269-283, 2003 | 271 | 2003 |
| Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines D O'Hagan, M Singh, M Ugozzoli, C Wild, S Barnett, M Chen, M Schaefer, ... Journal of virology 75 (19), 9037-9043, 2001 | 243 | 2001 |
| Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice A Wack, BC Baudner, AK Hilbert, I Manini, S Nuti, S Tavarini, H Scheffczik, ... Vaccine 26 (4), 552-561, 2008 | 239 | 2008 |
| Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells KS Denis-Mize, M Dupuis, ML MacKichan, M Singh, B Doe, D O'Hagan, ... Gene therapy 7 (24), 2105-2112, 2000 | 229 | 2000 |
| Endotoxin limits in formulations for preclinical research P Malyala, M Singh Journal of pharmaceutical sciences 97 (6), 2041-2044, 2008 | 217 | 2008 |
| Microparticle-based technologies for vaccines DT O’Hagan, M Singh, JB Ulmer Methods 40 (1), 10-19, 2006 | 209 | 2006 |
| Commentary: acceptable levels of endotoxin in vaccine formulations during preclinical research LA Brito, M Singh Journal of pharmaceutical sciences 100 (1), 34-37, 2011 | 207 | 2011 |
| Rational design of small molecules as vaccine adjuvants TYH Wu, M Singh, AT Miller, E De Gregorio, F Doro, U D’Oro, ... Science translational medicine 6 (263), 263ra160-263ra160, 2014 | 185 | 2014 |
